Biogen (BIIB) Assets Average (2009 - 2026)

Biogen has reported Assets Average for 18 years, with the latest figure at $30.8 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 9.24% year-over-year to $30.8 billion in Q2 2026; TTM through Jun 2026 was $30.8 billion, a 9.24% increase from a year earlier, with the FY2025 full-year figure at $28.7 billion, up 4.73% from the prior year.
• Assets Average was $30.8 billion for Q2 2026 at Biogen, up from $29.5 billion in the prior quarter.
• The five-year high for Assets Average was $30.8 billion in Q2 2026, with the low at $23.7 billion in Q1 2022.
• Average Assets Average over 5 years is $27.0 billion, with a median of $27.1 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Assets Average fell 2.03% in 2022, then gained 11.39% in 2023.
• Over 5 years, Assets Average stood at $24.7 billion in 2022, then grew by 11.39% to $27.5 billion in 2023, then advanced by 2.41% to $28.2 billion in 2024, then climbed by 4.05% to $29.3 billion in 2025, then increased by 4.98% to $30.8 billion in 2026.
• The last three Assets Average figures came in at $30.8 billion (Q2 2026), $29.5 billion (Q1 2026), and $29.3 billion (Q4 2025), per Business Quant data.